Weitere Artikel dieser Ausgabe durch Wischen aufrufen
Genetic mutations in the paraoxonase 1 (PON1) encoding gene have been considered to affect mortality and of these the functional promoter region polymorphisms Q192R and L55M are among the most widely studied.
The aim of this study was to determine whether the Q192R and L55M polymorphisms of PON1 can increase susceptibility to longevity. A meta-analysis was performed to obtain a comprehensive estimation of the association between Q192R and L55M and longevity in long-lived individuals (LLIs) aged 80 years or more.
A search was carried out in the PubMed database (from January 2001 to May 2014) to obtain data on the role of PON1 polymorphisms in longevity and a pooled odds ratio (OR) with a 95 % confidence interval (CI) was used to assess the associations.
The meta-analysis was based on 9 studies of PON1 Q192R and 5 studies of PON1 L55M that covered a total of 5086 LLIs and 4494 controls. Overall, significantly increased risks were not observed for either Q192R or L55M. The results of the statistical calculations were as follows: R vs. Q (additive model): OR = 1.080, 95 % CI = 0.989–1.179, p = 0.088 and RR + RQ vs. QQ (dominant model): OR = 1.099, 95 % CI = 0.975–1.240, p = 0.124; M vs. L (additive model): OR = 0.946, 95 % CI = 0.862–1.039, p = 0.245 and MM + ML vs. LL (dominant model): OR = 0.951, 95 % CI = 0.836–1.081, p = 0.442 for Q192R and L55M, respectively. The results did not change with an age cut-off among the LLIs of ≥ 93 years.
No evidence that the Q192R and L55M polymorphisms of PON1 impacted on the probability of reaching extreme ages was found although this cannot be completely ruled out; however, the possibility of population-specific effects due to the influence of and interaction between different genes or environmental factors could not be ruled out.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Rozek LS, Hatsukami TS, Richter RJ, Ranchalis J, Nakayama K, McKinstry LA, Gortner DA, Boyko E, Schellenberg GD, Furlong CE, Jarvik GP (2005) The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status. J Lipid Res 46:1888–1895 ([IF: 4.73]) PubMedCrossRef
Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RB, McCarthy A, Toker L, Silman I, Sussman JL, Tawfik DS (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11:412–419 ([IF: 11.633]) PubMedCrossRef
Rea IM, McKeown PP, McMaster D, Young IS, Patterson C, Savage MJ, Belton C, Marchegiani F, Olivieri F, Bonafe M, Franceschi C (2004) Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp Gerontol 39:629–635 ([IF: 3.529]) PubMedCrossRef
Pauk VV, Tuktarova IA, Nasibullin TR, Zueva LP, Adel’guzhina A, Khusnutdinova EK, Mustafina OE (2007) Paraoxonase 1 gene polymorphism 192Q/R in old men and long-livers from Tatars ethnic group. Mol Biol (Mosk) 41:601–607 CrossRef
Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B (2000) Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71:1062–1076 ([IF: 6.918]) PubMed
Thomas-MoyaE, Gianotti M, Proenza AM, Llado I (2007) Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol Med 13:203–209 ([IF: 4.824])
Talmud PJ, Stephens JW, Hawe E, Demissie S, Cupples LA, Hurel SJ, Humphries SE, Ordovas JM (2005) The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 69:613–622 ([IF: 1.926]) PubMedCrossRef
Nebel A, Croucher PJ, Stiegeler R et al (2005) No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans.Proc Natl Acad Sci USA 102(22):7906–7909
Campo S, Sardo MA, Trimarchi G et al (2004) Association between serum paraoxonase (PON1) genepromoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.Exp Gerontol 39(7):1089–1094
Blanche H, Cabanne L, Sahbatou M, Thomas G (2001) A study of French centenarians: are ACE and APOE associated with longevity? C R Acad Sci III 324(2):129–135
Heijmans BT, Westendorp RG, Lagaay AM et al (2000) Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis 149(1):91–97
Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity
Dr. Wen-Ru Tang
- Springer Berlin Heidelberg